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SCIENTIFIC LETTER
Bowman strip complications
during routine LASIK: Two cases
Scientiﬁc letterA
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lial  ingrowths  became  manifest  at  the  ﬂap’s  edges.  In  thedemonstrating the clinical
advantage of using Mitomicyn C
in  such cases
Complicaciones a nivel de una porción de la
membrana de Bowman durante la rutina del
procedimiento LASIK: dos casos que
demuestran la ventaja clínica del uso de
Mitomicina C en tales casos
Introduction
Bowman  strip  is  the  term  used  to  describe  a  portion  of  Bow-
man’s  layer  that  remains  exposed  at  the  posterior  surface
of  the  ﬂap.  The  incidence  of  intraoperative  complications
related  to  ﬂap  creation  during  LASIK  is  between  0.19%1
and  21.2%.2 Several  explanations  have  been  proposed  to
account  for  Bowman  strip  or  ‘‘buttonhole’’  complications
such  as:  steep  corneas,  partially  opened  eyes,  micro-
keratome  deﬁcits  such  as  blade  defect  and,  insufﬁcient
synchronization  between  the  movement  of  the  blade  and
microkeratome  translational  movement.  High  astigmatism,
or  conjunctival  entrapment  may  also  lead  to  Bowman  strip
or  buttonhole  ﬂap.4,5
Treatment  options  for  Bowman  strip  appear  to  depend
on  the  severity  of  the  complications  encountered.  Some
authors  recommend  waiting  three  months,  relifting  the
ﬂap,  bathing  the  bed  with  Mitomicyn  C  (MMC)  followed
by  surface  ablation.6,7 In  more  severe  profound  cases
it  is  recommended  to  wait  six  months,  relift  the  ﬂap,
apply  of  topical  MMC,  close  the  ﬂap  and  re-cutting  a new
ﬂap.8
We  report  our  experience  of  two  cases  where,  the  same
type  of  microkeratome  and  laser  platform  were  used  for
routine  LASIK  surgery.  In  both  cases,  Bowman  strip  was
encountered  with  thin  strip  of  epithelium  and  photo  ablation
was  completed  during  the  two  individual  surgical  events.
The  only  difference  was  that  in  one  case  we  applied  topical
0.02%  Mitomycin  C,  while  in  the  other  the  procedure  was
completed  without  any  additional  medications  or  interven-
tion.
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1888-4296/© 2014 Spanish General Council of Optometry. Published by E 42-year  old  male  patient  with  myopic  astigmatism  and  a
6-year  old  hyperopic  female  patient  were  referred  to  our
linic  for  laser  vision  correction.  First  patient’s  CDVA  was
.0  (Snellen)  with  −1.25DS/−1.00DCx85  in  the  right  eye
nd  with  −1.50DS/−0.75DCx150  in  his  left  eye,  while  sec-
nd  patient’s  CDVA  was  also  1.0  (Snellen)  with  +3.50DS  in
he  right  eye  and  with  +3.75DS  in  her  left  eye.  Preoperative
xamination  was  identical  for  both  patients  and  we  found
o  contraindications  for  the  surgery.  Steepest  keratometry
eadings  were  43.2D/42.8D  for  the  ﬁrst  and  43.8D/43.5D
or  the  second  patient.  Both  patients  underwent  routine
ASIK  procedure  with  90  m  microkeratome  ﬂap  (Moria  SA,
ntony,  France)  and  photoablation  with  the  Allegretto  Wave-
ight  400  Hz  excimer  laser  (Alcon  Laboratories,  Inc.  Forth
orth,  TX,  USA)  with  wavefront-guided  optimization.  Dur-
ng  the  lifting  of  the  ﬂaps,  a  signiﬁcant  central  Bowman  strip
as  observed  in  the  left  eye  of  the  ﬁrst  patient  and  both  eyes
f  the  second.  In  spite  of  these  ﬁndings,  we  continued  with
he  planned  photoablation  treatments  in  all  cases.  Prior  to
ap  repositioning,  the  ﬁrst  patient  did  not  receive  any  mod-
ﬁed  additional  treatment.  However,  for  the  second  patient
e  applied  topical  0.02%  Mitomycin  C  (MMC)  on  both  stro-
al  beds  for  20  s  just  before  closing  the  ﬂaps.  A  bandage
ontact  lens  (SofLens  59,  Bausch  &  Lomb,  Rochester,  NY,
SA)  was  placed  over  each  eye  and  kept  in  situ  for  7  days  fol-
owed  by  standard  postoperative  topical  therapy  consisting
f  antibiotic/corticosteroid  5  times/day  and  lubricant  eye
rops  8  times/day.  On  the  ﬁrst  day  post-op,  the  left  eye  of
he  ﬁrst  patient  had  developed  signiﬁcant  central  corneal
aze  grade  3  and  the  ﬂap  was  well  positioned.  The  second
atient  had  developed  very  slight  bilateral  central  corneal
aze  with  clear  strip  edges  and  stable  ﬁxed  ﬂaps.  For  the
rst  patient,  we  decided  to  extend  corticosteroid  treat-
ent  by  recommending  another  topical  corticosteroid  drops
Maxidex®),  because  the  patient  refused  to  take  any  oral
orticosteroids.  For  the  second  patient,  we  continued  with
 standard  unchanged  postoperative  regimen.  One  week
ost-op,  in  the  ﬁrst  patient’s  left  eye  CDVA  dropped  to  0.5
Snellen),  corneal  haze  had  reduced  slightly  but,  epithe-econd  patient  UCDVA  was  right  0.7  and  left  0.8  after  remov-
ng  the  bandage  lenses.  One  month  post-op,  the  left  eye
f  the  ﬁrst  patient  had  lost  another  line  of  CDVA  and  the
lsevier España, S.L.U. All rights reserved.
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esidual  refraction  was  pl/−1.25DCx60.  The  haze  was
nchanged  and  the  ingrowths  had  resolved.  The  biggest
roblem  we  faced,  other  than  the  unsatisﬁed  patient,
as  the  likelihood  of  secondary  glaucoma  due  to  pro-
onged  topical  corticosteroid  treatment.  We  decided  to
iscontinue  corticosteroids  replacing  with  non-steroid  anti-
nﬂammatory  drops  (NSAID).  The  second  patient  had
ilateral  UCDVA  of  1.0,  there  was  no  observable  corneal
aze  and  no  ingrowths,  but  the  boundary  edges  of  the  Bow-
an  strip  were  still  visible.  Two  months  postoperatively,  we
ecided  to  perform  surface  ablation  in  the  left  eye  of  the
rst  patient  in  order  to  correct  the  residual  refractive  error
nd  try  to  minimize  the  persistent  haze.  One  year  after  the
econd  procedure,  the  ﬁrst  patient  presented  with  no  sig-
iﬁcant  residual  refraction,  UCDVA  was  0.7,  slight  central
orneal  haze  was  still  present  but  without  any  epithelial
ngrowths.  Unfortunately,  at  this  point  the  patient  had  lost
hree  lines  of  his  CDVA  and  was  very  unsatisﬁed  with  the
utcome  in  his  left  eye.
iscussion
eal  buttonholes  or  Bowman  strips  rarely  occur  with  all
ypes  of  microkeratomes.  Nevertheless,  Gimbel  et  al.9 sug-
ested  that  the  Bowman  strip  complication  occurs  as  a
esult  of  excess  tissue  being  compressed  beyond  applana-
ion  by  the  keratome  footplate  causing  the  apical  cornea
o  buckle  inward.  Our  hypothesis  is  that,  for  the  two  cases
resented,  the  strips  occurred  because  of  inadequate  and
neven  suction  on  the  ring  occurred  during  the  keratome
otion  as  a  consequence  of  patient  anxiety  and  subsequent
ard  squeezing  of  the  eye  during  surgery.
Mitomycin  C  (MMC)  is  a  well  known  prophylactic  agent
sed  to  prevent  haze  formation  in  PTK  and  PRK11 and
or  reduction  of  postoperative  complications  after  LASIK
uttonhole.6 In  our  study,  a  methylcellulose  sponge  soaked
ith  0.02%  MMC  was  applied  for  20  s  and  not  for  60  s  as
ecommended  by  others.12 We  believe  that  a  20  s  period  is
ufﬁcient  to  achieve  the  desired  result  without  any  impact
n  surrounding  tissue.
There  is  a  major  difference  in  the  surgical  outcome  and
ecovery  when  comparing  cases  with  and  those  without  MMC
reatment.  Lane  et  al.5 in  their  case  report  found  no  haze,
o  epithelial  in  growth  and  excellent  visual  acuity  outcomes
0  days  after  the  surgery  with  Bowman  strip  and  MMC  topi-
al  application.  In  contrast  to  this,  Taneri  et  al.11 reported
arked  corneal  haze  and  progressive  epithelial  in  growth
ight  weeks  postoperatively  when  the  MMC  was  not  used.
ur  results  support  both  of  these  ﬁndings.  Mitomycin  C  is  an
ntineoplastic  drug  which  crosslinks  the  DNA  and  prevents
ts  replication  and  transcription.  Therefore,  it  is  very  useful
n  arresting  the  proliferation  of  active  ﬁbroblasts,  release  of
nﬂammatory  factors  and  prevention  of  epithelial  ingrowths.
ymionis  et  al.13 were  probably  the  ﬁrst  to  continue  with
hotoablation  when  Bowman  strip  or  buttonhole  formation
as  encountered  at  a  time  when  the  general  recommen-
ation  was  to  cease  the  surgical  procedure.  We  decided  to
ontinue  with  the  photoablation  of  corneal  stroma  because
he  Bowman  strip  was  very  thin  and  the  corneal  ﬂaps  were
ufﬁciently  adequate  in  size,  position  and  overall  integrity.
he  patient  with  MMC  topical  application  showed  excellent
esults  after  the  ablation,  comparing  to  the  patient  who  didSCIENTIFIC  LETTER
ot  have  MMC  before  ﬂap  repositioning.  The  reason  for  the
hallenged  refractive  outcome  in  the  non-MMC  case  could
e  associated  with  the  intrinsic  postoperative  tissue  inﬂam-
ation  and  healing  process.
In  conclusion,  based  on  all  said  above,  topical  application
f  MMC  for  20  s  during  LASIK  seems  to  be  a safe  and  effective
ourse  of  action  when  Bowman  strip  is  encountered.
inancial statement
e  hereby  certify  that  we  have  no  ﬁnancial  or  any  other
nterest  in  devices,  equipment  and  drugs  mentioned  in  this
tudy.
eferences
1. Al-Mezaine HS, Al-Amro SA, Al-Obeidan S. Incidence, manage-
ment, and visual outcomes of buttonhole laser in situ ker-
atomileusis ﬂaps. J Cataract Refract Surg. 2009;35:839--845.
2. Al-Mezaine HS, Al-Amro SA, Al-Fadda A, Al-Obeidan S. Out-
comes of retreatment after aborted laser in situ keratomileusis
due to ﬂap complications. Middle East Afr J Ophthalmol.
2011;18:232--237.
4. Pulaski JP. Etiology of buttonhole ﬂaps [letter]. J Cataract
Refract Surg. 2000;26:1270--1271.
5. Lane HA, Swale JA, Majmudar PA. Prophylactic use of
Mitomycin-C in the management of a buttonhole LASIK ﬂap.
J Cataract Refract Surg. 2003;29:390--392.
6. Leung AT, Rao SK, Cheng AC, Yu EW, Fan DS, Lam DS. Patho-
genesis and management of laser in situ keratomileusis ﬂap
buttonhole. J Cataract Refract Surg. 2000;26:358--362.
7. Rubinfeld RS, Hardten DR, Donnenfeld ED, et al. To lift or recut:
changing trends in LASIK enhancement. J Cataract Refract
Surg. 2003;29:2306--2317.
8. Harissi-Dagher M, Todani A, Melki SA. Laser in situ keratomileu-
sis buttonhole: classiﬁcation and management algorithm. J
Cataract Refract Surg. 2008;34:1892--1899.
9. Gimbel HV, Penno EE, van Westenbrugge JA, Ferensowicz
M, Furlong MT. Incidence and management of intraoperative
and early postoperative complications in 1000 consecu-
tive laser in situ keratomileusis cases. Ophthalmology.
1998;105:1839--1847.
11. Taneri S, Koch JM, Melki SA, Azar DT. Mitomycin-C assisted pho-
torefractive keratectomy in the treatment of buttonholed laser
in situ keratomileusis ﬂaps associated with epithelial ingrowth.
J Cataract Refract Surg. 2005;31:2026--2030.
12. Grupcheva CN, Malik TY, Craig JP, McGhee CNJ. In vivo confo-
cal microscopy of corneal epithelial ingrowth through a laser
in situ keratomileusis ﬂap buttonhole. J Cataract Refract Surg.
2001;27:1318--1322.
13. Kymionis GD, Portaliou DM, Karavitaki AE, et al. LASIK ﬂap but-
tonhole treated immediately by PRK with Mitomycin C. J Ref
Surg. 2010;26:225--228.
Bojan  Kozomaraa,∗, Maja  Bohacb,  Nikica  Gabricb,  Sudi
Patelb,c
a Svjetlost  Eye  Hospital,  Banja  Luka,  Bosnia  and
Herzegovina
b Svjetlost  University  Eye  Hospital,  Zagreb,  Croatia
c NHS  National  Services  Scotland,  Edinburgh,  UK∗ Corresponding  author  at:  Svjetlost  Eye  Hospital,  Bul.  D.
Maskimovic  12,  Banja  Luka,  Bosnia  and  Herzegovina.
E-mail  address:  bojan@svjetlost-banjaluka.ba
(B.  Kozomara).
